Free Trial

NanoVibronix (NAOV) Competitors

NanoVibronix logo
$1.15 -0.05 (-4.17%)
As of 04:00 PM Eastern

NAOV vs. DHAI, PAVM, SSKN, INBS, LUCY, NURO, CODX, STRR, POAI, and TNON

Should you be buying NanoVibronix stock or one of its competitors? The main competitors of NanoVibronix include DIH Holding US (DHAI), PAVmed (PAVM), STRATA Skin Sciences (SSKN), Intelligent Bio Solutions (INBS), Innovative Eyewear (LUCY), NeuroMetrix (NURO), Co-Diagnostics (CODX), Star Equity (STRR), Predictive Oncology (POAI), and Tenon Medical (TNON). These companies are all part of the "medical equipment" industry.

NanoVibronix vs. Its Competitors

NanoVibronix (NASDAQ:NAOV) and DIH Holding US (NASDAQ:DHAI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation, earnings and community ranking.

DIH Holding US has a net margin of -13.59% compared to NanoVibronix's net margin of -93.80%. DIH Holding US's return on equity of -5.07% beat NanoVibronix's return on equity.

Company Net Margins Return on Equity Return on Assets
NanoVibronix-93.80% -101.17% -53.03%
DIH Holding US -13.59%-5.07%-25.97%

In the previous week, NanoVibronix had 3 more articles in the media than DIH Holding US. MarketBeat recorded 4 mentions for NanoVibronix and 1 mentions for DIH Holding US. DIH Holding US's average media sentiment score of 1.87 beat NanoVibronix's score of 0.27 indicating that DIH Holding US is being referred to more favorably in the news media.

Company Overall Sentiment
NanoVibronix Neutral
DIH Holding US Very Positive

NanoVibronix received 71 more outperform votes than DIH Holding US when rated by MarketBeat users.

CompanyUnderperformOutperform
NanoVibronixOutperform Votes
71
56.80%
Underperform Votes
54
43.20%
DIH Holding USN/AN/A

16.4% of NanoVibronix shares are held by institutional investors. Comparatively, 27.8% of DIH Holding US shares are held by institutional investors. 7.0% of NanoVibronix shares are held by insiders. Comparatively, 49.6% of DIH Holding US shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

NanoVibronix has higher earnings, but lower revenue than DIH Holding US. DIH Holding US is trading at a lower price-to-earnings ratio than NanoVibronix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NanoVibronix$2.66M1.12-$3.71M-$13.53-0.08
DIH Holding US$64.47M0.17-$8.44M-$0.30-0.75

NanoVibronix has a beta of 1.75, indicating that its stock price is 75% more volatile than the S&P 500. Comparatively, DIH Holding US has a beta of 0.03, indicating that its stock price is 97% less volatile than the S&P 500.

Summary

DIH Holding US beats NanoVibronix on 9 of the 14 factors compared between the two stocks.

Get NanoVibronix News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAOV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NAOV vs. The Competition

MetricNanoVibronixSurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$2.97M$9.20B$5.61B$8.62B
Dividend YieldN/A1.26%5.28%4.17%
P/E Ratio-0.9320.9227.1419.96
Price / Sales1.1245.67411.83157.63
Price / CashN/A19.6738.2534.64
Price / Book0.595.137.064.69
Net Income-$3.71M$284.66M$3.23B$248.14M
7 Day Performance19.79%0.35%2.67%2.39%
1 Month Performance-72.02%-4.84%8.82%6.05%
1 Year Performance-87.55%-20.86%31.44%13.60%

NanoVibronix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAOV
NanoVibronix
0.298 of 5 stars
$1.15
-4.2%
N/A-86.4%$2.97M$2.66M-0.9320Short Interest ↑
DHAI
DIH Holding US
0.9589 of 5 stars
$0.23
-0.7%
N/A-89.9%$10.78M$64.47M-0.76N/APositive News
Gap Down
PAVM
PAVmed
3.8032 of 5 stars
$0.61
+1.5%
$19.50
+3,096.7%
-40.5%$10.43M$1.99M-0.1490
SSKN
STRATA Skin Sciences
2.6054 of 5 stars
$2.45
+0.9%
$6.00
+144.8%
-22.4%$10.22M$33.62M-0.92120Short Interest ↑
Gap Up
INBS
Intelligent Bio Solutions
0.4841 of 5 stars
$1.43
+1.4%
N/A+0.0%$9.88M$2.94M0.0010News Coverage
Positive News
LUCY
Innovative Eyewear
1.2282 of 5 stars
$3.12
-2.2%
N/A-72.2%$9.66M$1.71M-0.329Short Interest ↓
NURO
NeuroMetrix
N/A$4.55
+4.4%
N/A+19.7%$9.37M$3.03M-0.9920High Trading Volume
CODX
Co-Diagnostics
4.1566 of 5 stars
$0.26
+2.2%
$5.50
+2,005.7%
-80.8%$8.58M$3.71M-0.19100Short Interest ↑
STRR
Star Equity
2.8601 of 5 stars
$2.67
+12.2%
$5.00
+87.3%
-51.2%$8.57M$57.17M-1.04460Short Interest ↑
Gap Down
High Trading Volume
POAI
Predictive Oncology
1.9478 of 5 stars
$0.95
+7.9%
$3.00
+215.8%
-25.4%$8.49M$1.73M-0.3130News Coverage
Short Interest ↑
TNON
Tenon Medical
3.0629 of 5 stars
$1.08
flat
$4.67
+332.1%
+49.1%$8.20M$3.28M-0.048News Coverage
Positive News
Short Interest ↓

Related Companies and Tools


This page (NASDAQ:NAOV) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners